AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a significant milestone in its pancreatic cancer development program, with enrollment of the final subject, barring ...
Learn more Pfizer and Innovent Biologics have signed a global licensing and collaboration agreement worth up to $10.5bn for the research and development of a portfolio of 12 early-stage cancer ...
The U.S. Food and Drug Administration on Friday proposed to reduce animal studies conducted to assess safety in the development of certain cancer medications, marking the agency’s latest effort to ...
An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two years before patients were diagnosed.
The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug Summit Therapeutics and Akeso shared more data for their experimental lung-cancer drug ...
Hosted on MSN
New research suggests cancer may develop earlier than we thought — but simple changes can help prevent it
Cancer screening can feel like a rite of passage as we get older: skin cancer checks in your late 30s, a mammogram at age 40, a colonoscopy at age 45. However, as young cancer cases have skyrocketed, ...
E-cigarettes may carry cancer risks of their own, researchers warn. A doctor explains what people who vape and parents should ...
A distinct signaling pathway called TNF- drives the transformation of epithelial cells into aggressive tumor cells. During cancer progression, cells activate their own TNF- program and become invasive ...
A cancer diagnosis changes how people measure time. This article explores how advances in oncology research, precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results